-12%

est. 2Y upside i

HealthcareSeries A

Seed Health is a microbiome science company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough discoveries in microbial sciences across a pipeline of novel therapeutics, consumer health innovations and environmental solutions. All consumer innovations in probiotics are commercialized under Seed®.

Rank

#2591

Sector

Biotechnology

Est. Liquidity

~2Y

Data Quality

Data: Medium

Seed has a strong moat and profitability, but the entry valuation of $1B is based on a stale mark from a 2021 Series A, and no growth rate is provided.

Last updated: July 19, 2026

Bull (25%)+23%

Seed achieves IPO, sustaining a 6x forward revenue multiple on $210M revenue (implied market cap $1.26B). Net of 10% dilution, upside is 23.4%.

Base (50%)-14%

Multiple converges to 4x, in line with comps. Revenue grows to $210M, implied value $840M. Net of dilution, downside of 14.4%.

Bear (25%)-43%

Multiple contracts to 2.5x due to competitive pressure or failed sale. Revenue $210M yields $525M. Preference stack minimal, common suffers 42.75% loss net of dilution.

Est. time to liquidity~2.0 years

Preference Stack Risk

low

Funding Intensity

4%

Total funding of $44M represents only 4.4% of valuation; common stock is unlikely to be wiped out by preference in most scenarios.

Dilution Risk

low

Company is profitable, likely no near-term raise; assumed 10% dilution from option pool over 2 years.

Secondary Liquidity

none

No secondary market data available; shares are illiquid until M&A or IPO.

View all 5 open roles at Seed →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Seed's data — designed to show you've done your homework.

  • 1

    “How does Seed plan to defend against large consumer health companies acquiring competitors or launching rival products?”

  • 2

    “What is the subscription retention rate and lifetime value, and how do you plan to improve unit economics?”

  • 3

    “Given the potential sale, what is the likely timeline for liquidity, and how would that affect the vesting schedule?”

Community

Valuation Sentiment

Our model estimates -12% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.